Genomic Valley Biotech Ltd.

BSE: 539206

₹44.70

up-down-arrow ₹-0.01 (-0.02%)

As on 18-Nov-2026IST

Market cap

info icon

₹14 Cr

Revenue (TTM)

info icon

₹0 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

3.5

Div. Yield

info icon

0 %

Genomic Biotech Share Price

Compare

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 43.56 High: 44.71

52 Week Range

Low: 20.10 High: 61.37

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹0 Cr

  • ROEROE information

    9.6 %

  • ROCEROCE information

    11.9 %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    1046.8

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    ₹12.8

  • EPSEPS information

    ₹-0

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    3,054,500

10 Years Aggregate

CFO

₹-1.48 Cr

EBITDA

₹1.35 Cr

Net Profit

₹0.60 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Genomic Biotech
80.9 30.3 51.3 51.3 25.3 -- --
BSE Healthcare
21.3 9.1 3.9 17.3 21.3 15.6 13.4
As on 18-Nov-2026
Company
2025
2024
Genomic Biotech
-69.8 103.4
BSE Small Cap
-6.6 29.0
BSE Healthcare
-3.3 43.1

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Genomic Biotech
44.7 13.7 0.1 0.0 7.1 -0 -- 3.5
121.2 1,901.0 2,756.2 -115.8 1.0 -1.7 -- 0.3
655.0 15,751.6 4,130.9 411.1 12.4 13.1 38.3 4.7
89.8 321.5 145.3 -4.9 -3.4 -4.5 -- 3.4
294.5 13,385.9 3,391.5 565.7 20.0 17.6 23.9 4.0
1,788.1 38,099.8 2,371.5 376.2 21.7 14.8 101.3 14.2
3,532.3 8,126.4 979.0 279.7 36.4 76.4 29.1 19.1
12.4 188.0 114.0 8.7 0.3 26.8 21.5 5.5
15.4 34.0 59.2 -2.6 15.2 -16 -- 0.4

Shareholding Pattern

View Details
loading...

News & Analysis

All News

No Review & Analysis are available.

About Genomic Biotech

Wholesale of agricultural raw materials and live animals

  • Incorporated

    1994

  • Chairman

    --

  • Managing Director

    Yogesh Agrawal

  • Headquarters

    Jhajjar Dist, Haryana

  • Website

    www.genomicvalley.com

FAQs for Genomic Biotech

The share price of Genomic Valley Biotech Ltd is ₹44.70 (BSE) as of 18-Nov-2026 IST. Genomic Valley Biotech Ltd has given a return of 25.32% in the last 3 years.

Since, TTM earnings of Genomic Valley Biotech Ltd is negative, P/E ratio is not available.
The P/B ratio of Genomic Valley Biotech Ltd is 3.48 times as on 18-Nov-2026, a 6 premium to its peers’ median range of 3.29 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
50.26
4.59
2024
698.34
2.99
2023
0.00
0.00
2022
0.00
0.00
2021
0.00
0.00

The 52-week high and low of Genomic Valley Biotech Ltd are Rs 61.37 and Rs 20.10 as of 18-Nov-2026.

Genomic Valley Biotech Ltd has a market capitalisation of ₹ 14 Cr as on 18-Nov-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Genomic Valley Biotech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...
loading...
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month